| Walgreen Pharmacy # 11244 | |
| 15155 Nw Higway 441, Alachua, Florida 32615 | |
| (386) 418-3782 |
| Name | Walgreen Pharmacy # 11244 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 15155 Nw Higway 441, Alachua, Florida 32615 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (386) 418-3782 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
OncoVista Innovative Therapies, Inc. reported today that two of its proprietary products, the AdnaTest™ BreastCancer and AdnaTest EMT1/StemCell, were evaluated in Germany by the Departments of Gynecology and Obstetrics and Internal Medicine (Cancer Research) at University Hospital Essen, University of Duisburg-Essen and the Department of Gynecology and Obstetrics, University Hospital of Tuebingen.
The drug topiramate can help people lose weight as long as they can tolerate the side effects, according to authors of a new study that reviewed the medical literature. Brazilian researchers will present the results Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
Doctors may be able to predict their patients' risks of fatal coronary heart disease more accurately by taking into account the number of adverse social factors affecting them, according to a new study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Integra LifeSciences Holdings Corporation today reported its financial results for the first quarter ending March 31, 2010. Total revenues for the first quarter were $172.7 million, reflecting an increase of $11.7 million, or 7%, over the first quarter of 2009. Excluding the impact of currency exchange rates, revenues increased 6% over the first quarter of 2009.
› Verified 6 days ago
| NPI Number | 1922252394 |
| Organization Name | WALGREEN CO. |
| Doing Business As | WALGREENS #11244 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 15155 Nw Us Highway 441, Alachua, FL 32615 |
| Phone Number | 386-418-3785 |
News Archive
OncoVista Innovative Therapies, Inc. reported today that two of its proprietary products, the AdnaTest™ BreastCancer and AdnaTest EMT1/StemCell, were evaluated in Germany by the Departments of Gynecology and Obstetrics and Internal Medicine (Cancer Research) at University Hospital Essen, University of Duisburg-Essen and the Department of Gynecology and Obstetrics, University Hospital of Tuebingen.
The drug topiramate can help people lose weight as long as they can tolerate the side effects, according to authors of a new study that reviewed the medical literature. Brazilian researchers will present the results Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
Doctors may be able to predict their patients' risks of fatal coronary heart disease more accurately by taking into account the number of adverse social factors affecting them, according to a new study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Integra LifeSciences Holdings Corporation today reported its financial results for the first quarter ending March 31, 2010. Total revenues for the first quarter were $172.7 million, reflecting an increase of $11.7 million, or 7%, over the first quarter of 2009. Excluding the impact of currency exchange rates, revenues increased 6% over the first quarter of 2009.
› Verified 6 days ago
News Archive
OncoVista Innovative Therapies, Inc. reported today that two of its proprietary products, the AdnaTest™ BreastCancer and AdnaTest EMT1/StemCell, were evaluated in Germany by the Departments of Gynecology and Obstetrics and Internal Medicine (Cancer Research) at University Hospital Essen, University of Duisburg-Essen and the Department of Gynecology and Obstetrics, University Hospital of Tuebingen.
The drug topiramate can help people lose weight as long as they can tolerate the side effects, according to authors of a new study that reviewed the medical literature. Brazilian researchers will present the results Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.
The controversy over recent breast cancer screening guidelines offers an opportunity to engage individual patients in an informed discussion of the importance of evidence-based clinical efficacy assessments in contributing to better care decisions, Donna Sweet, MD, MACP today told the Subcommittee on Health of the House Energy and Commerce Committee. Dr. Sweet testified at a hearing, Breast Cancer Screening Recommendations, on behalf of the American College of Physicians (ACP).
Doctors may be able to predict their patients' risks of fatal coronary heart disease more accurately by taking into account the number of adverse social factors affecting them, according to a new study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Integra LifeSciences Holdings Corporation today reported its financial results for the first quarter ending March 31, 2010. Total revenues for the first quarter were $172.7 million, reflecting an increase of $11.7 million, or 7%, over the first quarter of 2009. Excluding the impact of currency exchange rates, revenues increased 6% over the first quarter of 2009.
› Verified 6 days ago
Hitchcock's Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15560 Nw Us Highway 441, Alachua, Florida 32615 Phone: (386) 418-1444 | |
Cvs Pharmacy #05222 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15174 Nw Us Rte 441, Alachua, Florida 32616 Phone: (386) 462-1323 | |
Publix Pharmacy #1505 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 16193 Nw Us Hwy 441, Alachua, Florida 32615 Phone: (863) 418-3435 | |
Walgreen Pharmacy # 11244 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15155 Nw Higway 441, Alachua, Florida 32615 Phone: (386) 418-3782 |